1887
Surveillance Open Access
Like 0

Abstract

Following the rapid increase of infections due to carbapenemase-producing Enterobacteriaceae (CPE) in Italy, the national surveillance of bloodstream infections (BSI) due to CPE ( and ) was instituted in 2013. All CPE-BSI cases reported to the surveillance in the years 2014–17 were analysed in order to investigate incidence rate (IR), trend, main individual characteristics and enzymes involved in CPE resistance. Throughout this period, 7,632 CPE-BSI cases (IR: 3.14/100,000 inhabitants) were reported from all 21 regions and autonomous provinces in Italy, with an increasing number of reported cases (2014: 1,403; 2015: 1,838; 2016: 2,183; 2017: 2,208). CPE-BSI cases mainly occurred in subjects aged over 60 years (70.9%) and more frequently in males (62.7%) than in females. Most of the cases originated in hospitals (87.2%), mainly in intensive care units (38.0%), and were associated with central or peripheral venous catheter use (23.9%) or with urinary tract infections (21.1%). Almost all CPE-BSI (98.1%) were due to carrying the carbapenemase (KPC) enzyme (95.2%). These data show that carbapenemase-producing are endemic in our country, causing a high number of BSI and representing a threat to patient safety.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2019.24.5.1800159
2019-01-31
2019-05-26
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2019.24.5.1800159
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/24/5/eurosurv-24-5-3.html?itemId=/content/10.2807/1560-7917.ES.2019.24.5.1800159&mimeType=html&fmt=ahah

References

  1. van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017;8(4):460-9.  https://doi.org/10.1080/21505594.2016.1222343  PMID: 27593176 
  2. Girmenia C, Serrao A, Canichella M. Epidemiology of carbapenem resistant Klebsiella pneumoniae infections in mediterranean countries. Mediterr J Hematol Infect Dis. 2016;8(1):e2016032.  https://doi.org/10.4084/mjhid.2016.032  PMID: 27441063 
  3. Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785-96.  https://doi.org/10.1016/S1473-3099(13)70190-7  PMID: 23969216 
  4. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25(4):682-707.  https://doi.org/10.1128/CMR.05035-11  PMID: 23034326 
  5. Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012;18(5):413-31.  https://doi.org/10.1111/j.1469-0691.2012.03821.x  PMID: 22507109 
  6. Nordmann P, Poirel L. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect. 2014;20(9):821-30.  https://doi.org/10.1111/1469-0691.12719  PMID: 24930781 
  7. van Duin D, Doi Y. Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae: Are We at the End of the Road? J Clin Microbiol. 2015;53(10):3116-7.  https://doi.org/10.1128/JCM.01399-15  PMID: 26202122 
  8. Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S, et al. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill. 2014;19(42):20939.  https://doi.org/10.2807/1560-7917.ES2014.19.42.20939  PMID: 25358041 
  9. van Duin D, Cober ED, Richter SS, Perez F, Cline M, Kaye KS, et al. Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance. Clin Microbiol Infect. 2014;20(12):O1117-20.  https://doi.org/10.1111/1469-0691.12714  PMID: 24931918 
  10. Adeolu M, Alnajar S, Naushad S, S Gupta R. Genome-based phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. Int J Syst Evol Microbiol. 2016;66(12):5575-99.  https://doi.org/10.1099/ijsem.0.001485  PMID: 27620848 
  11. Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis. 2012;55(7):943-50.  https://doi.org/10.1093/cid/cis588  PMID: 22752516 
  12. Borer A, Saidel-Odes L, Riesenberg K, Eskira S, Peled N, Nativ R, et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol. 2009;30(10):972-6.  https://doi.org/10.1086/605922  PMID: 19712030 
  13. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309-18.  https://doi.org/10.1179/2047773215Y.0000000030  PMID: 26343252 
  14. Otter JA, Burgess P, Davies F, Mookerjee S, Singleton J, Gilchrist M, et al. Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective. Clin Microbiol Infect. 2017;23(3):188-96.  https://doi.org/10.1016/j.cmi.2016.10.005  PMID: 27746394 
  15. Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasević AT, et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis. 2017;17(2):153-63.  https://doi.org/10.1016/S1473-3099(16)30257-2  PMID: 27866944 
  16. Giani T, Pini B, Arena F, Conte V, Bracco S, Migliavacca R, et al. Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011. Euro Surveill. 2013;18(22):20489. PMID: 23787077 
  17. Sisto A, D’Ancona F, Meledandri M, Pantosti A, Rossolini GM, Raglio A, et al. Carbapenem non-susceptible Klebsiella pneumoniae from Micronet network hospitals, Italy, 2009 to 2012. Euro Surveill. 2012;17(33):20247. PMID: 22913976 
  18. European Centre for Disease Prevention and Control (ECDC). Surveillance Atlas of Infectious Diseases tool. Stockholm: ECDC. [Accessed 8 Jan 2019]. Available from. https://ecdc.europa.eu/en/antimicrobial-resistance/surveillance-and-disease-data/data-ecdc
  19. Giani T, Antonelli A, Caltagirone M, Mauri C, Nicchi J, Arena F, et al. Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients. Euro Surveill. 2017;22(31):30583.  https://doi.org/10.2807/1560-7917.ES.2017.22.31.30583  PMID: 28797330 
  20. Luzzaro F, Pagani L, Rossolini GM, Sarti M, Stefani S, Varaldo PE. Indicazioni per la conferma fenotipica della produzione di carbapenemasi nelle Enterobacteriaceae. Comitato di Studio Associazione Microbiologi Clinici Italiana (AMCLI) per gli Antimicrobici (CoSA) [Indications for phenotypic confirmation of carbapenemase production in Enterobacteriaceae. Study Committee of the Italian Clinical Microbiology Association (AMCLI) for Antimicrobials (CoSA)]. 2011.
  21. Barbarini D, Russello G, Brovarone F, Capatti C, Colla R, Perilli M, et al. Evaluation of carbapenem-resistant Enterobacteriaceae in an Italian setting: report from the trench. Infect Genet Evol. 2015;30:8-14.  https://doi.org/10.1016/j.meegid.2014.11.025  PMID: 25444940 
  22. Sabbatucci M, Iacchini S, Iannazzo S, Farfusola C, Marella AM, Bizzotti V, et al. Sorveglianza nazionale delle batteriemie da enterobatteri produttori di carbapenemasi. Rapporto 2013-2016 [National Surveillance of bacteraemia due to carbapenemase-producing Enterobacteriaceae. Report 2013–2016]. Rapporti ISTISAN 17/18. Rome: Istituto Superiore di Sanità: 2017. Italian. [Accessed 10 Jan 2019]. Available from: http://old.iss.it/publ/index.php?lang=1&id=3065&tipo=5
  23. Ministero della Salute (Italian Ministry of Health). Rapporto annuale sull’attività di ricovero ospedaliero. Dati SDO 2016. [Annual report on hospitalisations. 2016 data]. Rome: Ministry of Health. Italian. Available from: http://www.salute.gov.it/imgs/C_17_pubblicazioni_2651_allegato.pdf
  24. Istituto Nazionale di Statistica (ISTAT). National Institute of Statistics. Population estimates for Italy 2014. Rome: ISTAT. [Accessed 8 Jan 2019]. Italian. Available from: http://www.demo.istat.it/pop2014/index.html
  25. Istituto Nazionale di Statistica (ISTAT). National Institute of Statistics. Population estimates for Italy 2015. Rome: ISTAT. [Accessed 8 Jan 2019]. Italian. Available from: http://www.demo.istat.it/pop2015/index.html
  26. Istituto Nazionale di Statistica (ISTAT). National Institute of Statistics. Population estimates for Italy 2016. Rome: ISTAT. [Accessed 8 Jan 2019]. Italian. Available from: http://www.demo.istat.it/pop2016/index.html
  27. Istituto Nazionale di Statistica (ISTAT). National Institute of Statistics. Population estimates for Italy 2017. Rome: ISTAT. [Accessed 8 Jan 2019]. Italian. Available from: http://www.demo.istat.it/pop2017/index.html
  28. Information Services Division (ISD) Scotland. European standard population 2013. Edinburgh: ISD. [Accessed 8 Jan 2019]. Available from: https://www.isdscotland.org/Products-and-Services/GPD-Support/Population/Standard-Populations
  29. Calia C, Pazzani C, Oliva M, Scrascia M, Lovreglio P, Capolongo C, et al. Carbapenemases-producing Klebsiella pneumoniae in hospitals of two regions of Southern Italy. APMIS. 2017;125(5):491-8.  https://doi.org/10.1111/apm.12666  PMID: 28295617 
  30. Del Franco M, Paone L, Novati R, Giacomazzi CG, Bagattini M, Galotto C, et al. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d’Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789). BMC Microbiol. 2015;15(1):260.  https://doi.org/10.1186/s12866-015-0597-z  PMID: 26552763 
  31. Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DLEuropean Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill. 2015;20(45):30062.  https://doi.org/10.2807/1560-7917.ES.2015.20.45.30062  PMID: 26675038 
  32. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546-54.  https://doi.org/10.1056/NEJMoa022139  PMID: 12700374 
  33. Uslan DZ, Crane SJ, Steckelberg JM, Cockerill FR 3rd, St Sauver JL, Wilson WR, et al. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med. 2007;167(8):834-9.  https://doi.org/10.1001/archinte.167.8.834  PMID: 17452548 
  34. Vading M, Nauclér P, Kalin M, Giske CG. Invasive infection caused by Klebsiella pneumoniae is a disease affecting patients with high comorbidity and associated with high long-term mortality. PLoS One. 2018;13(4):e0195258.  https://doi.org/10.1371/journal.pone.0195258  PMID: 29624618 
  35. Kousouli E, Zarkotou O, Politi L, Polimeri K, Vrioni G, Themeli-Digalaki K, et al. Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens. Eur J Clin Microbiol Infect Dis. 2018;37(1):43-50.  https://doi.org/10.1007/s10096-017-3098-1  PMID: 28879405 
  36. Hubacek JA, Stüber F, Fröhlich D, Book M, Wetegrove S, Ritter M, et al. Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis. Crit Care Med. 2001;29(3):557-61.  https://doi.org/10.1097/00003246-200103000-00015  PMID: 11373419 
  37. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626-38.  https://doi.org/10.1038/nri.2016.90  PMID: 27546235 
  38. Weng NP. Aging of the immune system: how much can the adaptive immune system adapt? Immunity. 2006;24(5):495-9.  https://doi.org/10.1016/j.immuni.2006.05.001  PMID: 16713964 
  39. Holt PG, Jones CA. The development of the immune system during pregnancy and early life. Allergy. 2000;55(8):688-97.  https://doi.org/10.1034/j.1398-9995.2000.00118.x  PMID: 10955693 
  40. European Centre for Disease Prevention and Control (ECDC). Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae – first update. Stockholm: ECDC. 2018. Available from: https://ecdc.europa.eu/sites/portal/files/documents/RRA-Enterobacteriaceae-Carbapenems-European-Union-countries.pdf
  41. Ministero della Salute (Italian Ministry of Health). Piano Nazionale di Contrasto dell’Antimicrobico-Resistenza (PNCAR) 2017-2020. [National Action Plan on Antimicrobial Resistance 2017-2020] Rome: Ministry of Health; 24 Oct 2017. Italian. Available from: http://www.salute.gov.it/imgs/C_17_pubblicazioni_2660_allegato.pdf
/content/10.2807/1560-7917.ES.2019.24.5.1800159
Loading

Data & Media loading...

Supplementary data

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error